Outset Medical Q1 2024 Adj EPS $(0.57) Misses $(0.55) Estimate, Sales $28.168M Miss $30.341M Estimate
Outset Medical Q1 2024 Adj EPS $(0.57) Misses $(0.55) Estimate, Sales $28.168M Miss $30.341M Estimate
Outset Medical 2024年第一季度调整后每股收益美元（0.57）未达到预期（0.55），销售额为2816.8万美元，低于3,0341万美元的预期
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 3.64 percent. This is a 20.83 percent increase over losses of $(0.72) per share from the same period last year. The company reported quarterly sales of $28.168 million which missed the analyst consensus estimate of $30.341 million by 7.16 percent. This is a 15.83 percent decrease over sales of $33.467 million the same period last year.
Outset Medical（纳斯达克股票代码：OM）公布的季度亏损为每股0.57美元，比分析师普遍预期的0.55美元（0.55美元）低3.64％。这比去年同期每股亏损0.72美元（0.72美元）增长了20.83％。该公司公布的季度销售额为2816.8亿美元，比分析师普遍预期的303.41亿美元低7.16％。这比去年同期的3,346.7万美元的销售额下降了15.83％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。